首页> 美国卫生研究院文献>Clinical Orthopaedics and Related Research >Clinical Results of Bone Ingrowth TKA in Patients with Rheumatoid Arthritis
【2h】

Clinical Results of Bone Ingrowth TKA in Patients with Rheumatoid Arthritis

机译:类风湿性关节炎患者骨生长的TKA的临床结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients with rheumatoid arthritis (RA) often are not considered for TKA with bone ingrowth fixation because of poor bone quality, but we asked whether implants with sintered metal bead surfaces could be used to durably fix implants in this group of patients. We prospectively evaluated a consecutive series of 47 patients (64 knees) between January 1, 1994, and December 30, 2001, in two separate medical centers using one TKA system. Standard primary implants were used in all knees except those with major bone defects, and in these patients we used long diaphyseal stems to stabilize the implants. Minimum followup was 61 months (mean ± standard deviation, 83 ± 6 months; range, 61–124 months). Survivorship was 98.4% at 10 years postoperatively. No components failed because of loosening. One femoral component was revised for fracture because of a massive intraosseous rheumatoid cyst. No knees had radiographic evidence of migration or widening radiolucent lines. Knee Society clinical, pain, and function scores improved after surgery and were maintained throughout followup. These data suggest bone ingrowth implants can provide durable fixation in patients with RA.>Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
机译:由于骨质较差,通常不考虑类风湿关节炎(RA)患者进行骨内生长固定的TKA,但我们询问是否可以将具有烧结金属珠表面的植入物持久地固定在该组患者中。我们前瞻性地评估了从1994年1月1日至2001年12月30日在两个单独的医疗中心使用一个TKA系统连续进行的47例患者(64膝)的一系列病例。除了具有严重骨缺损的膝盖以外,所有膝关节均使用标准的主要植入物,在这些患者中,我们使用了长的干骨干来稳定植入物。最小随访时间为61个月(平均±标准偏差为83±6个月;范围为61-124个月)。术后10年生存率为98.4%。没有组件因松动而发生故障。由于巨大的骨内类风湿性囊肿,一个股骨组件被修订用于骨折。没有膝盖有放射学证据证明有迁移或放射线增宽的迹象。膝关节学会的临床,疼痛和功能评分在手术后得到改善,并在整个随访过程中保持不变。这些数据表明骨长入植入物可以为RA患者提供持久的固定。>证据级别: IV级,治疗研究。有关证据水平的完整说明,请参见《作者指南》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号